new
humanpathogen
parvoviru
human
bocaviru
hbov
recent
discov
associ
respiratori
diseas
small
children
howev
mani
patient
present
low
viral
dna
load
suggest
hbov
persist
render
polymeras
chain
reactionbas
diagnosi
problemat
moreov
noth
known
hbov
immun
examin
hbovspecif
system
b
cell
respons
assess
diagnost
use
young
children
respiratori
diseas
patient
method
pair
serum
sampl
children
acut
wheez
previous
studi
respiratori
virus
test
immunoblot
assay
use
recombin
hbov
capsid
antigen
uniqu
part
viru
protein
viru
protein
result
viru
protein
superior
uniqu
part
viru
protein
respect
immunoreact
accord
viru
protein
assay
children
posit
hbov
accord
polymeras
chain
reaction
immunoglobulin
ig
antibodi
igg
antibodi
exhibit
igm
antibodi
andor
increas
igg
antibodi
level
patient
increas
antibodi
level
high
load
hbov
dna
nasopharynx
support
hypothesi
high
hbov
dna
load
indic
acut
primari
infect
wherea
low
load
seem
less
clinic
signific
subgroup
patient
previous
determin
acut
hbov
infect
defin
high
viru
load
nasopharynx
viremia
absenc
viral
infect
patient
serolog
evid
primari
infect
control
group
children
wheez
polymeras
chain
reaction
result
neg
hbov
nasopharynx
igm
antibodi
includ
display
increas
igg
antibodi
level
virem
crossreact
human
parvoviru
detect
conclus
respiratori
infect
due
hbov
system
elicit
b
cell
immun
respons
diagnos
serolog
serolog
diagnos
correl
high
viru
load
nasopharynx
viremia
serolog
test
accur
tool
disclos
associ
hbov
infect
diseas
viral
infect
lower
airway
major
caus
morbid
even
mortal
infant
small
children
classic
perpetr
rhinoviru
respiratori
syncyti
viru
influenza
viru
parainfluenza
viru
adenoviru
interest
newcom
sever
acut
respiratori
syndrom
coronaviru
human
metapneumoviru
recent
human
bocaviru
hbov
also
caus
sever
diseas
hbov
discov
pool
nasopharyng
aspir
npa
procedur
name
molecular
viru
screen
includ
random
pcr
largescal
sequenc
bioinformat
subsequ
sequenc
phylogenet
analysi
hbov
genom
dna
show
viru
taxonom
closest
newli
establish
genu
bocaviru
parvovirida
famili
second
humanpathogen
parvoviru
known
first
parvoviru
caus
rash
arthropati
anemia
fetal
death
human
parvovirus
includ
adenoassoci
virus
newli
found
parvoviru
unknown
clinic
impact
closest
rel
hbov
bocavirus
bovin
parvoviru
canin
minut
viru
infect
cow
dog
respect
anim
bocaviru
infect
mostli
subclin
howev
diseas
associ
canin
minut
viru
bovin
parvoviru
includ
reproduct
failur
enter
neonat
respiratori
diseas
sinc
discoveri
hbov
shown
worldwid
one
common
virus
respiratori
secret
dna
preval
depend
greatli
studi
design
includ
laboratori
technolog
patient
age
symptom
hbov
typic
found
children
year
age
hospit
lower
respiratori
tract
diseas
wherea
healthi
children
adult
gener
pcr
result
neg
hbov
thu
grow
evid
exist
hbov
humanpathogen
viru
caus
acut
lower
respiratori
diseas
infant
young
children
howev
larg
number
patient
present
low
viral
load
suggest
hbov
persist
make
pcrbase
diagnosi
problemat
nevertheless
studi
perform
viru
far
base
pcr
detect
littl
known
hbovspecif
b
cell
immun
aim
studi
find
whether
symptomat
hbov
infect
pediatr
patient
elicit
system
antibodi
respons
whether
respons
use
diagnosi
hbov
infect
children
respiratori
diseas
patient
sampl
collect
children
age
month
year
admit
depart
pediatr
turku
univers
hospit
turku
finland
septemb
may
acut
expiratori
wheez
observ
describ
elsewher
admiss
hospit
npa
viral
diagnosi
obtain
standard
procedur
blood
sampl
collect
hospit
admiss
week
hospit
discharg
pair
serum
sampl
store
children
includ
previou
viru
etiolog
studi
compris
pcr
studi
npa
virus
adenoviru
hbov
coronavirus
enterovirus
rhinovirus
influenza
b
virus
human
metapneumoviru
parainfluenza
viru
respiratori
syncyti
viru
shown
hbov
posit
pcr
pair
serum
sampl
hbovposit
children
mean
age
year
rang
month
year
avail
present
studi
pair
serum
sampl
randomli
select
wheez
children
mean
age
year
rang
month
year
npa
hbovneg
pcr
result
studi
includ
control
subject
durat
symptom
eg
cough
prior
hospit
admiss
mean
day
rang
day
hospit
time
mean
h
rang
h
base
data
avail
children
studi
approv
ethic
committe
turku
univers
hospit
turku
finland
helsinki
univers
hospit
helsinki
finland
recombin
antigen
product
fulllength
viru
protein
uniqu
region
viru
protein
hbov
capsid
gene
correspond
nucleotid
respect
amplifi
highfidel
pcr
plasmid
contain
near
fulllength
hbov
clone
genbank
access
primer
includ
recognit
site
restrict
enzym
tabl
amplicon
clone
express
vector
novagen
use
standard
clone
practic
transform
escherichia
coli
express
host
plyss
invitrogen
protein
product
e
coli
strain
harbor
kept
shake
l
luria
broth
terrif
broth
medium
respect
contain
mgml
ampicillin
mgml
chloramphenicol
cultur
reach
induc
h
mm
isopropyl
bdthiogalactosid
cell
harvest
centrifug
min
g
room
temperatur
resuspend
ml
pb
lyse
sonic
ice
protein
purifi
denatur
condit
affin
chromatographi
use
ninta
resin
qiagen
accord
manufactur
instruct
serolog
test
immunoblot
assay
purifi
protein
sampl
separ
page
transfer
onto
nitrocellulos
membran
protran
ba
whatman
schleicher
schuell
block
min
block
buffer
dri
milk
pb
room
temperatur
treat
human
serum
sampl
block
buffer
igg
dilut
igm
dilut
h
room
temperatur
final
horseradish
peroxidaseconjug
antihuman
igg
igm
dilut
block
buffer
ad
peroxidas
activ
demonstr
h
step
sheet
wash
time
min
pb
contain
tween
stain
band
visual
regard
neg
posit
equivoc
result
consid
neg
score
done
knowledg
result
pcr
hbov
serum
sampl
also
test
parvoviru
igm
igg
antibodi
commerci
igg
igm
biotrin
inhous
epitop
typespecif
igg
eia
quantit
pcr
pair
serum
sampl
children
npa
posit
hbov
pcr
studi
earlier
quantit
pcr
target
gene
remain
serum
sampl
except
sampl
children
unavail
underw
hbov
dna
amplif
dna
purifi
ml
serum
qiaamp
dna
blood
mini
kit
qiagen
elut
ml
ml
use
total
reaction
volum
ml
taqman
univers
pcr
master
mix
pe
appli
biosystem
use
pcr
perform
accord
alland
et
al
except
thermal
cycler
qpcr
system
stratagen
set
min
follow
cycl
min
posit
quantifi
result
obtain
copiesml
hbov
plasmid
avoid
contamin
sampl
pcr
mixtur
prepar
laminar
flow
hood
separ
room
water
use
neg
control
express
hbov
protein
protein
express
bacteria
express
analyz
sd
page
figur
show
appar
molecular
weight
kda
kda
respect
protein
yield
good
case
cultur
sampl
result
mg
affin
purifi
recombin
protein
hbov
immunoblot
pair
serum
sampl
wheez
children
appli
onto
immunoblot
membran
harbor
antigen
recombin
hbov
capsid
protein
detect
human
bocavirusspecif
igg
igm
antibodi
repres
result
shown
figur
children
igg
antibodi
igm
antibodi
major
capsid
protein
actual
experienc
seroconvers
also
exhibit
igm
antibodi
serodiagnos
occur
children
age
year
alland
et
al
suggest
high
hbov
dna
load
npa
copiesml
indic
primari
symptomat
infect
wherea
lower
viral
load
like
reflect
viru
persist
group
hbovposit
pcr
result
therefor
subdivid
accord
dna
load
npa
group
high
viral
load
exhibit
diagnost
antibodi
result
compar
patient
low
viral
load
group
tabl
patient
igg
antibodi
increas
seroconvers
high
viral
load
group
furthermor
group
children
hbov
sole
pcr
find
hbov
monoinfect
tabl
diagnost
result
igm
antibodi
increas
igg
antibodi
level
experienc
seroconvers
patient
initi
regard
hbov
monoinfect
later
found
harbor
nontyp
picornaviru
note
virem
children
high
load
dna
npa
hbov
pcr
find
hbov
serodiagnosi
among
children
pcr
result
posit
hbov
coinfect
anoth
respiratori
viru
hbov
serodiagnosi
tabl
children
pcrposit
npa
serum
sampl
posit
pcr
result
tabl
dna
level
rang
copiesml
control
group
children
hbovneg
npa
accord
pcr
diagnost
result
igm
antibodi
increas
igg
antibodi
level
experienc
seroconvers
tabl
note
control
patient
igg
increas
serum
sampl
pcr
result
posit
hbov
ie
particular
control
patient
inde
ongo
hbov
infect
even
though
npa
reproduc
pcr
neg
children
pcrneg
npa
virem
viral
load
copiesml
tabl
total
preval
hbov
igg
first
serum
sampl
includ
group
wheez
children
hbovneg
npa
accord
pcr
mean
age
year
rang
month
year
seropreval
among
differ
age
group
follow
month
age
month
age
n
p
year
age
year
age
n
p
n
p
year
age
year
n
p
n
p
age
n
p
accord
antibodi
assay
children
igg
igm
increas
igg
describ
figur
serodiagnos
correl
npa
pcr
result
serodiagnos
occur
children
viremia
diagnost
result
data
shown
seven
iggposit
children
igg
antibodi
antigen
serolog
test
serum
sampl
studi
parvoviru
igm
igg
antibodi
diagnost
find
posit
igm
low
epitopetyp
specif
index
seen
among
children
hbov
serodiagnos
entir
clinic
materi
singl
diagnosi
encount
hbovseroneg
child
control
group
altogeth
children
igg
antibodi
hbov
igg
antibodi
children
hbov
igg
antibodi
igg
antibodi
compar
hbov
iggneg
children
data
shown
success
express
purifi
hbov
major
capsid
protein
full
length
uniqu
part
minor
capsid
protein
togeth
span
entir
put
capsidprotein
code
region
protein
use
detect
human
bocavirusspecif
igg
igm
anti
bodi
pair
serum
sampl
children
acut
wheez
among
wheez
children
major
group
similar
age
distribut
compar
children
harbor
bocaviru
dna
nasopharynx
group
children
hbovposit
pcr
result
subdivid
accord
amount
hbov
dna
detect
also
accord
whether
hbov
sole
find
outlin
tabl
antibodi
result
show
antigen
superior
immunoreact
surpris
comparison
humanpathogen
parvoviru
immunoreact
contain
mani
neutral
epitop
inde
region
success
use
diagnosi
infect
one
possibl
reason
dissimilar
virus
might
differ
locat
within
capsid
could
affect
access
host
immun
hbov
immunoblot
assay
overal
seropreval
rate
low
correl
hbovposit
npa
pcr
howev
assay
seem
specif
diagnos
confirm
assay
pcr
serum
sampl
contrast
assay
children
hbovposit
npa
pcr
seroposit
onehalf
exhibit
marker
igm
antibodi
increas
igg
antibodi
level
acut
viral
infect
serodiagnos
occur
children
high
viru
load
furthermor
among
group
wheez
children
fulfil
nonserolog
criteria
acut
hbov
infect
includ
viremia
high
viral
load
npa
lack
virus
patient
subgroup
show
serolog
evid
acut
infect
control
group
npa
hbovneg
pcr
children
show
diagnost
igg
increas
note
found
hbovposit
serum
sampl
pcr
indic
ongo
system
hbov
infect
total
wheez
children
hbovneg
npa
pcr
virem
emphas
need
diagnost
tool
even
technic
problem
pcr
clinic
sampl
time
rule
possibl
explan
pcr
neg
serodiagnost
virem
case
interest
altern
explan
could
system
hbov
infect
without
viru
shed
respiratori
tract
inde
high
preval
npa
hbovposit
pcr
result
high
number
seroconvers
group
high
viral
load
suggest
sampl
time
gener
appropri
hand
patient
npa
hbovposit
pcr
result
almost
low
viru
load
without
serodiagnosi
children
also
nonvirem
could
sever
explan
eg
superfici
infect
without
system
immun
persist
viral
dna
nasopharynx
follow
earlier
infect
hbov
age
group
common
could
wide
circul
among
children
day
care
within
famili
therebi
easili
contamin
airway
line
high
frequenc
pcr
result
posit
hbov
high
preval
coinfect
respiratori
virus
inde
among
wheez
children
studi
patient
hbov
monoinfect
also
onehalf
coinfect
virus
exhibit
serodiagnosi
hbov
infect
indic
hbov
also
occur
system
individu
coinfect
consid
diagnosi
respiratori
diseas
preval
hbov
igg
group
wheez
children
npa
pcr
result
neg
hbov
mean
age
year
rang
month
year
base
assay
howev
regard
gener
hbov
seropreval
age
group
fact
children
enrol
basi
respiratori
symptom
accord
pcr
acut
hbov
infect
shown
preval
children
age
month
year
possibl
children
month
age
protect
matern
antibodi
studi
howev
children
young
month
age
coinfect
group
control
group
none
hbov
seroposit
seropreval
seem
increas
age
reach
maximum
among
children
year
age
decreas
among
children
year
age
decreas
suggest
denatur
antigen
inher
immunoblot
method
might
recogn
past
immun
antibodi
older
children
timerel
conform
depend
characterist
b
cell
immun
viru
phenomenon
addit
superfici
mucos
infect
could
also
explain
patient
low
viral
load
igg
posit
line
hypothesi
viru
persist
long
infect
evid
serolog
crossrecognit
human
bovin
parvovirus
specif
bocaviru
bovin
parvoviru
observ
even
though
latter
virus
phylogenet
distant
capsid
protein
sequenc
similar
low
ensur
antibodi
would
crossreact
hbov
thu
interfer
result
children
examin
b
cell
immun
howev
iggposit
children
among
hbov
iggneg
group
among
hbov
iggposit
group
furthermor
children
found
posit
hbov
igm
therefor
among
patient
antibodi
interfer
hbov
antibodi
result
alland
et
al
found
hbov
dna
npa
wheez
children
high
hbov
dna
load
infect
hbov
infect
associ
low
viru
load
howev
preval
suggest
reflect
viru
persist
high
viral
load
viremia
note
mainli
absenc
respiratori
virus
suggest
caus
role
hbov
acut
wheez
present
studi
serodiagnost
find
strongli
support
causal
low
viral
load
nasopharynx
thu
seem
littl
clinic
signific
even
though
immunoblot
assay
use
intend
final
diagnost
tool
find
clearli
show
diagnost
valu
serolog
test
acut
hbov
infect
diagnost
criteria
bocaviru
infect
current
unsettl
use
hbovposit
pcr
result
npa
criterion
case
acut
hbov
infect
evidenc
viremia
andor
serodiagnost
find
would
miss
furthermor
number
fals
diagnos
would
obtain
perhap
result
persist
hbov
dna
mucos
contamin
serolog
test
coupl
quantit
pcr
includ
diagnost
shown
strengthen
causal
associ
hbov
respiratori
diseas
combin
diagnost
tool
possibl
also
evalu
clinic
manifest
possibl
caus
hbov
pediatr
gastroenter
whether
context
extent
viru
affect
immunocompromis
individu
pregnant
women
elderli
individu
current
unknown
addit
knowledg
neutral
capac
longev
hbov
immun
also
requir
shown
knowledg
first
time
respiratori
infect
due
hbov
elicit
system
b
cell
respons
compris
igm
igg
also
show
main
target
respons
major
capsid
protein
wherea
uniqu
region
minor
protein
less
immunoreact
measur
hbovspecif
antibodi
possibl
identifi
acut
hbov
infect
small
children
hospit
sever
respiratori
diseas
maximum
diagnost
power
quantit
pcr
serolog
test
perform
